FDA considers its position on vexed topic of device reuse
This article was originally published in Clinica
The US FDA has finally agreed to take a stand on the reuse of single-use devices, a controversial issue it has been ducking for years, even though parties on all sides have been urging it to act. Last week the agency announced that it would offer a "straw man" proposal no later than October outlining what the agency "thinks it will do".
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.